Court recommends $54m judgment in Abbott TM case

Federal magistrate proposes awarding Abbott millions of dollars from 85 companies and individuals for selling unauthorised diabetes test strips | Judge advises a permanent injunction in almost a decade old trademark case.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Abbott settles grey market goods dispute with pharmacy

21 July 2017 Abbott Laboratories has settled its dispute with a Florida-based pharmacy accused of selling grey market goods.

Americas

More than 300 parties barred from selling ‘grey market’ Abbott goods

4 November 2016 The US Court of Appeals for the Second Circuit has affirmed a ruling of a district court in a trademark infringement dispute between Abbott Laboratories and pharmacies, distributors and individuals.

Americas

Abbott succeeds in grey goods injunction request

12 November 2015 Abbott Laboratories has successfully obtained an injunction against a number of US retailers selling ‘grey good’ strips for diabetics that had been manufactured in Ireland and later sold in the US at a lower price.

More features

Trade secrets go global: How brand owners face a high-stakes battlefront

Killing the golden goose of US drug innovation (Part II): Drug pricing myths

Former pharma GC brings in-house perspective to McGuireWoods

Sandoz eyes US biosimilar launch as Regeneron settles

Killing the golden goose of US drug innovation (Part I): Follow the money

Buchalter brings in new partner to head up medtech

Trump’s march-in rights threat: Why pharma is rethinking collaborations

UK gets new IP minister following cabinet reshuffle

Court recommends $54m judgment in Abbott TM case

More on this story

Editor's picks

Editor's picks

More features